For several decades, neurotrophic factors have been confined within th
e Geld of basic neuroscience and their suspected importance for human
neurological diseases rested on ideas and hypothesis rather than on fa
cts. More recently, the progress in molecular biology techniques have
allowed the production of high amounts of recombinant neurotrophic fac
tors and the construction of animal models of neurodegenerative diseas
es. The picture is currently changing up to the point that clinical tr
ials are now in progress. Certainly some of them have given or will gi
ve disappointing results but we anticipate that major progress in the
management of neurological disorders will result, if not from the use
of neurotrophic factors themselves, at least from treatments based upo
n the concepts and data generated within this field of basic neuroscie
nce.